Page 1257 - Small Animal Clinical Nutrition 5th Edition
P. 1257
INDEX 1309
Odontoclastic resorptive lesions, in cats, 982, 983b, 998-999c, central vein infusion, 486-487
1010-1011 clinical importance, 477-478
Oils (See individual oils) compounding solutions for, 485-486, 486f
VetBooks.ir Oligosaccharides (See Fructooligosaccharide) dextrose-fat ratios in solutions for, 481-483
drug additions, 484t, 485, 485t
Olfactory physiology, 323-325
Omega-3 fatty acids (See Fatty acids) electrolyte solutions for, 484
Omega-6 fatty acids (See Fatty acids) energy solutions for, 480
Omnivore, dogs as omnivores, 252-253 example calculations for cats, 479-480t
Onion toxicosis, 230t, 235, 372b, 435-436c example calculations for dogs, 479-480t
Oral disorders (See Periodontal disease) metabolic complications of, 491t
Oral rehydration solutions, 1055t monitoring parameters, 490-491
Orthopedic disease (See Developmental orthopedic disease other routes of infusion, 488
and Osteoarthritis) patient criteria for, 478t
Osmolality/osmolarity, of parenteral products, 480, 483, 483t, peripheral vein infusion, 487-488
486-487 products for, 478-485, 481t,
Osteoarthritis, 695-713 protein solutions for, 483-484
assessment of, 695-699, 697t, 700f risks and complications, 487b, 488-489,
clinical importance of, 695-699 trace-element solutions for, 485
commercial foods for, 709t vitamin solutions for, 484-485
etiopathogenesis, 698-699 Peanut hulls, 74f, 79t, 81t, 91t
feeding plan for, 707-711, 709f Pearson square, 12-14, 14f, 1121b
key nutritional factors for, 699-707, 701t Pectin, 73, 74f
nutriceuticals, 704-706, 705b Pellicle (dental), 983
physical rehabilitation for, 708b Periodontal disease, 979-1001
risk factors for, 698 assessment of, 980-982
use of fatty acids as treatment for, 700-704, 701f, 702f chew toys, effects on, 994b, 998c
Osteochondritis dissecans (OCD) (See Osteochondrosis) clinical importance of, 979
Osteochondrosis, 667-668, 668f, 672t, 675 clinical signs associated with, 987t
Otitis externa, association with adverse food reactions, 610, etiopathogenesis of, 982-986, 985f
623-624 feeding plan for, 991-994
Ovariohysterectomy, effects of (See Neuter) food forms, effects on, 986-989, 989f
Oxalate (See Calcium oxalate urolithiasis) key nutritional factors for, 986-990
prevalence of, 980
P risk factors for, 981-982
Palatability stages of, 985f, 985t
factors affecting, 168-169 systemic complications of, 984-985
enhancers, 170 treats, effects on, 992-993
of low-sodium foods, 754b, Perianal fistulas in dogs, dietary management of, 1119b
testing for palatability preference, 167-170 Pet food (Commercial pet foods), 157-190
Pancreatic enzyme preparations, 1140t acceptability/acceptance of food, 167-168
Pancreatic insufficiency (See Exocrine pancreatic insufficien- addiction, 170
cy) additives, 176-177
Pancreatitis (acute and chronic), 1143-1153 digestibility of, 170-171
assessment of, 1143-1147 dry (extruded),159-160
clinical importance of, 1143 features and benefits of, 166
commercial foods for, 1149t, 1150t, 1151t feeding costs of, 171
etiopathogenesis of, 1146-1147 forms of, 158-161, 160f
feeding plan for patients with, 1148-1151 ingredient myths and facts, 173b
key nutritional factors for, 1147, 1147t ingredients (commercial foods), 171-177
risk factors for, 1145-1146, 1145t labels (See Pet food labels)
Pantothenic acid, function, metabolism and sources of, 135- marketing concepts for, 162
136 all-purpose foods, 162
canine blood levels, 132t specific-purpose foods, 162
feline blood levels, 132t moist (canned), 158
requirements/deficiencies/excesses, 124t preference testing of food, 167-168
Parathyroid hormone (See also Hyperparathyroidism), 670t, segments, 165-166, 164f
772, 777f, 788f, 824-825t, 859t, 943 semi-moist, 160
association with developmental orthopedic disease of dogs, shelf life of, 159, 175, 176, 182, 183, 184, 189-190
670, 670t soft-dry, 160
association with urolithiasis, 873-874 temperature, effects on consumption, 169
Parenteral-assisted feeding, 477-498 veterinary therapeutic foods, 166, 167b
administration of, 486-488 Pet food labels, 191-206